Randomized Controlled Trial to Evaluate the Efficacy of the SALFOAM 3% Method Compared to the Conventional Polidocanol Foam Method (Tessari Method) for Treating Lower Limb Varicose Veins

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 18, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

March 31, 2025

Conditions
Varicose Veins
Interventions
PROCEDURE

SALFOAM 3%

"* Drug: Polidocanol 3%~* Device: Lidstop®"

PROCEDURE

Control Group

"* Drug: Polidocanol 3%~* Device: Standard compression with dental roll and elastic stockings"

Trial Locations (1)

Unknown

RECRUITING

Hospital São Luiz Gonzaga, São Paulo

All Listed Sponsors
collaborator

Lidiane Aparecida Ferreira Rocha

UNKNOWN

lead

Lidiane Rocha

OTHER

NCT06667570 - Randomized Controlled Trial to Evaluate the Efficacy of the SALFOAM 3% Method Compared to the Conventional Polidocanol Foam Method (Tessari Method) for Treating Lower Limb Varicose Veins | Biotech Hunter | Biotech Hunter